echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > By the end of the year, 97 negotiated drugs will be online on provincial-level centralized purchase platforms

    By the end of the year, 97 negotiated drugs will be online on provincial-level centralized purchase platforms

    • Last Update: 2019-12-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] in order to promote the implementation of the national health insurance negotiation drugs in 2019, the National Health Insurance Bureau and the national health and Health Commission jointly issued the notice of the national health and Health Commission on the implementation of the national health insurance negotiation drugs in 2019 (hereinafter referred to as the "notice") to ensure that the majority of insured patients can enjoy the relevant treatment as scheduled According to the notice, each provincial medical insurance department shall directly hang 97 negotiated drugs on the provincial drug centralized purchase platform within the prescribed time limit, i.e before December 31 Timely organize medical institutions and drug manufacturers to sign agreements, and medical institutions shall purchase according to the agreements For negotiation drugs suitable for outpatient treatment, with long service cycle and high treatment cost, the burden of patients can be reduced by including special disease guarantee in outpatient service and exploring single disease payment according to fund income and expenditure Measures can be taken to encourage alternative use of drugs that are more cost-effective and can be completely replaced than the original drugs in the medical insurance catalogue before the negotiation On November 28, the state health insurance bureau released the list of drugs to enter the national health insurance negotiation in 2019 97 drugs were successfully negotiated, with an average price reduction of 60.7% These 97 drugs involve more than 10 clinical treatment fields such as cancer, rare disease, hepatitis, diabetes, rheumatism immunity, cardio cerebrovascular, digestion, etc From the perspective of key areas, all five essential drugs were negotiated successfully, 22 anticancer drugs, 7 drugs for rare diseases, 14 drugs for chronic diseases (including diabetes, hepatitis B, rheumatoid arthritis, etc.) and 4 drugs for children were negotiated successfully It can be seen that the structure of medical insurance catalog has been further optimized The big price cuts include hepatitis C drugs, cancer drugs, diabetes drugs and so on Among them, the average decrease rate of three kinds of hepatitis C treatment drugs is more than 85%, and the average decrease rate of cancer, diabetes and other treatment drugs is about 65% Xiong Xianjun, director of the medical service management department of the State Medical Security Bureau, said at the conference earlier, "it is conservatively estimated that through negotiations on price reduction and medical insurance reimbursement, the individual burden of patients will be reduced to less than 20% of the original level, and that of individual drugs will be reduced to less than 5%." It can be seen that for patients who need to take drugs for a long time, the drug cost burden will be greatly reduced Take diabetes patients as an example According to the data released by the International Diabetes Union in 2017, the number of people with diabetes in China has reached 114 million It is understood that most diabetics spend from one or two hundred to thousands of yuan a month on drugs For those who rely on drugs every day to maintain normal blood sugar levels, it's a big expense over the years With the introduction of diabetes drugs into medical insurance and substantial price reduction, patients will be able to enjoy drugs with better effect and lower price According to the requirements of the notice, all designated medical institutions shall be equipped and reasonably used in a timely manner according to their functional orientation, clinical needs and diagnosis and treatment capabilities, and shall not influence the configuration and use of negotiated drugs on the basis of the total amount control of medical insurance, the number limit of drug directories of medical institutions, the proportion of drugs, etc In addition, all localities should establish a monitoring mechanism for the use of negotiated drugs, strengthen statistical monitoring on the allocation, use and payment of negotiated drugs, and report to the state health insurance bureau (medical service management department) monthly summary by provincial health insurance departments from January to June 2020 This also means that all aspects of the configuration and use of negotiated drugs will be strictly supervised, which is conducive to ensuring that negotiated drugs really benefit patients The industry believes that this is the continuation of the policy after the national health insurance negotiation, and will further improve some mechanisms, so as to promote the implementation of drugs for health insurance negotiation as soon as possible, facilitate the use of patients, and reduce the burden of patients' drug costs.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.